Introduction {#s1}
============

In in vitro cell cultures and in infected individuals, viruses may display two types of replication strategies: cell-free infection and cell-to-cell infection ([@bib26]; [@bib14]; [@bib29]). Both transmission means require the assembly of infectious virus particles ([@bib15]), which are released in the extracellular medium for cell-free transmission, or concentrated in the confined space of cell-to-cell contacts between an infected cell and bystander target cells in the case of cell-to-cell transmission. It has been shown that most enveloped virus species, including human immunodeficiency virus type 1 (HIV-1), a causative agent of AIDS, spread via cell-to-cell infection, and it is considered that the replication efficacy of cell-to-cell infection is much higher than that of cell-free infection ([@bib26]; [@bib14]; [@bib29]). However, it is technically impossible to let viruses execute only cell-to-cell infection. In addition, since these two infection processes occur in a synergistic (i.e., nonlinear) manner, the additive (i.e., linear) idea that 'total infection' minus 'cell-free infection' is equal to 'cell-to-cell infection' does not hold true universally. Hence, it was difficult to estimate and compare the efficacies of cell-free and cell-to-cell infection, and different reports provided different estimates ([@bib5]; [@bib3]; [@bib4]; [@bib28]; [@bib32]). Thus, the quantitative information that underlies cell-to-cell infection has yet to be elucidated and its impact on virus spread remains unclear.

In this study, through coupled experimental and mathematical investigation, we demonstrate that the efficacy of cell-to-cell HIV-1 infection is 1.4-fold higher than that of cell-free infection (i.e., cell-to-cell infection accounts for approximately 60% of total infection). We also show that the cell-to-cell infection shortens the generation time of viruses by 0.9 times, and increases the viral fitness by 3.9 times. These findings strongly suggest that the cell-to-cell infection plays a critical role in efficient and rapid spread of viral infection. Furthermore, we discuss the role of the cell-to-cell infection in HIV-1 infected individuals, based on in silico simulation with our estimated parameters.

Results {#s2}
=======

Adaptation of a mathematical model to explicitly consider cell-free and cell-to-cell infection {#s2-1}
----------------------------------------------------------------------------------------------

A static cell culture system (i.e., a conventional cell culture system) allows viruses to perform both cell-free and cell-to-cell infection. On the other hand, Sourisseau et al. have reported that the cell-to-cell infection can be prevented by mildly shaking the cell culture infected with viruses ([@bib28]). Consistent with the previous report ([@bib28]), we verified that shaking did not induce nonspecific consequences on HIV-1 infection ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). To quantitatively estimate the efficacy of the cell-free infection and that of the cell-to-cell infection respectively, we adopted this experimental method (see 'Materials and methods'). Static cultures of Jurkat cells, an HIV-1-susceptible human CD4^+^ T-cell line, allow HIV-1 to propagate both by the cell-free and cell-to-cell infection, while under shaking conditions, Jurkat cells allows HIV-1 to replicate only by the cell-free infection ([Figure 1A](#fig1){ref-type="fig"}).10.7554/eLife.08150.003Figure 1.Cell culture systems and the basic reproduction number under cell-to-cell and cell-free infection.(**A**) Static and shaking cultures of Jurkat cells. The static and shaking cell cultures allow human immunodeficiency virus type 1 (HIV-1) to perform both cell-free and cell-to-cell infection, and only cell-free infection, respectively. (**B**) The basic reproduction number, *R*~0~, is defined as the number of the secondly infected cells produced from a typical infected cell during its infectious period. In the presence of the cell-to-cell and cell-free infection, the basic reproduction number consists of two sub-reproduction numbers through the cell-free infection, *R*~*cf*~, and through the cell-to-cell infection, *R*~*cc*~, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.08150.003](10.7554/eLife.08150.003)

Previous mathematical models, which have been widely used for data analyses, essentially describe only the cell-free infection ([@bib17]; [@bib20]; [@bib8], [@bib9]) or implicitly both infection modes ([@bib11]; [@bib13], [@bib12]). Here we used the following revised model including both infection modes explicitly:$$\frac{dT\left( t \right)}{dt} = gT\left( t \right)\left( {1 - \frac{T\left( t \right) + I\left( t \right)}{T_{max}}} \right) - \beta T\left( t \right)V\left( t \right) - \omega T\left( t \right)I\left( t \right),$$$$\frac{dI\left( t \right)}{dt} = \beta T\left( t \right)V\left( t \right) + \omega T\left( t \right)I\left( t \right) - \delta I\left( t \right),$$$$\frac{dV\left( t \right)}{dt} = pI\left( t \right) - cV\left( t \right),$$where *T*(*t*) and *I*(*t*) are the numbers of uninfected and infected cells per ml of a culture, respectively, and *V*(*t*) is the viral load measured by the amount of HIV-1 p24 per ml of culture supernatant. The target cells (we used Jurkat cells) grow at a rate *g* with the carrying capacity of *T*~max~ (the maximum number of cells in the cell culture flask). The parameters *β*, *δ*, *p* and *c* represent the cell-free infection rate, the death rate of infected cells, the virus production rate, and the clearance rate of virions, respectively. Note that *c*, *g*, and *δ* include the removal of virus, and of the uninfected and infected cells, due to the experimental samplings. In our earlier works ([@bib8], [@bib9]; [@bib6]; [@bib10]), we have shown that the approximating punctual removal as a continuous exponential decay has minimal impact on the model parameters and provides an appropriate fit to the experimental data. In addition, we introduce the parameter *ω*, describing the infection rate via cell-to-cell contacts ([@bib28]; [@bib26]; [@bib27]). In the shaking cell culture system, we fixed *ω* = 0 because the shaking inhibits the formation of cell-to-cell contacts completely ([@bib28]). In previous reports, Komarova et al. used a quasi-equilibrium approximation for the number of free virus, and incorporated the dynamics of *V*(*t*) into that of *I*(*t*) in [@bib11], [@bib13], and [@bib12]. However, in cell culture system, the clearance of virions usually is not much larger than the death rate of infected cells, like in vivo (see below). This fact does not validate the quasi-equilibrium approximation, and it may affect the quantification of the dynamics of the cell-to-cell and cell-free infection. We introduced the above full model, relying on a carefully designed experiment, to accurately extract the quantitative information that underlies HIV-1 infection. Furthermore, our experimental datasets include all time-series of the number of uninfected, infected cell, and virions. Thus, our coupled experimental and mathematical investigations with a sufficient datasets allowed us to estimate all parameters in [Equations 1](#equ1){ref-type="disp-formula"}--[3](#equ3){ref-type="disp-formula"}, and to compute the basic reproduction number, generation time, and Malthus coefficient (see below).

Data fitting to quantify the cell-free and cell-to-cell contribution to HIV spread {#s2-2}
----------------------------------------------------------------------------------

Correctly estimated parameter sets with possible variation are required to reproduce model prediction for pure cell-to-cell infection in silico. However, point estimation of the model parameter set by a conventional ordinary least square method does not capture possible variations of kinetic parameters and model prediction. To assess the variability of kinetic parameters and model prediction, we perform Bayesian estimation for the whole dataset using Markov Chain Monte Carlo (MCMC) sampling (see 'Materials and methods' and [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}), and simultaneously fit [Equations 1](#equ1){ref-type="disp-formula"}--[3](#equ3){ref-type="disp-formula"} with *ω* \> 0 and *ω* = 0 to the concentration of p24-negative and -positive Jurkat cells and the amount of p24 viral protein in the static and shaking cell cultures, respectively. Here we note that *g* and *T*~max~ were separately estimated and fixed to be 0.47 ± 0.10 for the static culture and 0.54 ± 0.09 for the shaking culture per day, and (1.51 ± 0.02) × 10^6^ and (1.22 ± 0.02) × 10^6^ cells per flask of medium from the cell growth experiments, respectively (see 'Materials and methods', [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"} and [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). In addition, we used *c* value of 2.3 per day, which is estimated from daily harvesting of viruses (i.e., the amount of p24 have to be reduced by around 90% per day by the daily medium-replacement procedure).

The remaining four common parameters *β*, *ω*, *δ* and *p*, along with the six initial values for *T*(0), *I*(0) and *V*(0) in the static and the shaking cell cultures, were determined by fitting the model to the data. Experimental measurements, which were below the detection limit, were excluded in the fitting. The estimated parameters of the model and derived quantities are given in [Table 1](#tbl1){ref-type="table"}, and the estimated initial values are summarized in [Supplementary file 3](#SD3-data){ref-type="supplementary-material"}. The typical behavior of the model using these best-fit parameter estimates is shown together with the data in [Figure 2](#fig2){ref-type="fig"}, which reveals that [Equations 1](#equ1){ref-type="disp-formula"}--[3](#equ3){ref-type="disp-formula"} describe these in vitro data very well. The shadowed regions correspond to 95% posterior predictive intervals, the dashed lines give the best-fit solution (mean) for [Equations 1](#equ1){ref-type="disp-formula"}--[3](#equ3){ref-type="disp-formula"}, and the dots show the experimental datasets. This suggests that the parameters that were estimated are representative for the various processes underlying the HIV-1 kinetics including the cell-to-cell and cell-free infection.10.7554/eLife.08150.004Table 1.Parameters estimated by mathematical-experimental analysis**DOI:** [http://dx.doi.org/10.7554/eLife.08150.004](10.7554/eLife.08150.004)Parameter nameSymbolUnitExp. 1Exp. 2Exp. 3Ave. ± S.D.Parameters obtained from simultaneous fit to time-course experimental dataset Rate constant for cell-free infection*β*10^−6^ × (p24 day)^−1^5.59[\*](#tblfn1){ref-type="table-fn"} (3.54--8.41)[†](#tblfn2){ref-type="table-fn"}3.27 (2.05--5.01)[‡](#tblfn3){ref-type="table-fn"}3.70 (2.28--5.77)4.18 ± 1.41 Rate constant for cell-to-cell infection*ω*10^−6^ × (cell day)^−1^0.88 (0.45--1.39)1.25 (0.70--1.97)1.13 (0.64--1.79)1.09 ± 0.33 Production rate of total viral protein*p*day^−1^0.37 (0.22--0.59)0.59 (0.34--0.92)0.54 (0.31--0.86)0.50 ± 0.16 Death rate of infected cells*δ*day^−1^0.45 (0.32--0.64)0.54 (0.38--0.75)0.50 (0.36--0.68)0.50 ± 0.10Quantities derived from fitted values Basic reproduction number through cell-free infection*R*~*cf*~--2.88 (2.34--3.53)2.27 (1.98--2.66)2.43 (2.04--2.95)2.44 ± 0.23 Basic reproduction number through cell-to-cell infection*R*~*cc*~--2.95 (1.48--4.70)3.65 (1.77--6.05)3.39 (1.82--5.38)3.39 ± 0.91 Basic reproduction number*R*~0~--5.83 (4.20--7.75)5.92 (3.99--8.46)5.83 (4.21--7.89)5.83 ± 0.94 Contribution of cell-to-cell infection$\frac{R_{cc}}{R_{cf} + R_{cc}}$--0.50 (0.34--0.63)0.60 (0.44--0.72)0.57 (0.43--0.70)0.57 ± 0.07[^2][^3][^4]10.7554/eLife.08150.005Figure 2.Dynamics of HIV-1 infection in Jurkat cells through cell-free and cell-to-cell infection.Jurkat cells were inoculated with HIV-1 (at multiplicity of infection 0.1) in the static and shaking cell cultures. Panels **A** and **B** show the time-course of experimental data for the numbers of uninfected cells (top) and infected cells (middle), and the amount of viral protein p24 (bottom) in the static and shaking cell culture systems, respectively. The shadow regions correspond to 95% posterior predictive intervals, the dashed curves give the best-fit solution (mean) for [Equations 1](#equ1){ref-type="disp-formula"}--[3](#equ3){ref-type="disp-formula"} to the time-course dataset. All data in each experiment were fitted simultaneously. In panels **A** and **B**, the results of three independent experiments are respectively shown.**DOI:** [http://dx.doi.org/10.7554/eLife.08150.005](10.7554/eLife.08150.005)10.7554/eLife.08150.006Figure 2---figure supplement 1.No effect of the shaking procedure on HIV-1 cell-free infection.Jurkat cells were infected with HIV-1 (at multiplicity of infection 1) as described in 'Materials and methods', and the infected cells were cultured in the static and the shaking condition. By harvesting the cells at 24 and 48 hr postinfection, the cells were analyzed by flow cytometry as described in 'Materials and methods'. The percentage of the average of p24-positive cells are shown with SD. The assay was performed in triplicate, and the representative result is shown. Note that the ratio of input virus to target cells (multiplicity of infection) of this experiment is 10-fold higher than that of the experiment shown in [Figure 2](#fig2){ref-type="fig"}. This is for the clear detection of the infected cells (p24-positive cells) during early time points.**DOI:** [http://dx.doi.org/10.7554/eLife.08150.006](10.7554/eLife.08150.006)10.7554/eLife.08150.007Figure 2---figure supplement 2.Dynamics of Jurkat cell growth.Dynamics of Jurkat cell growth in the static and shaking cell cultures. By harvesting the cells for 37 days (**A**) in the static and (**B**) in the shaking cell cultures, the growth kinetics of Jurkat cells in these conditions was estimated as described in Materials and methods.**DOI:** [http://dx.doi.org/10.7554/eLife.08150.007](10.7554/eLife.08150.007)10.7554/eLife.08150.008Figure 2---figure supplement 3.Dot plots of infected cells by flow cytometry.Representative results of flow cytometry (experiment 1). Time-course results of flow cytometry analyses on experiment 1 of static (left) and shaking (right) cultures are respectively shown. The cells positive for p24 antigen is gated in pink, and the number in the bottom right of the gate indicates the percentage of p24-positive cells. The data is available upon request.**DOI:** [http://dx.doi.org/10.7554/eLife.08150.008](10.7554/eLife.08150.008)

Our model (i.e., [Equations 1](#equ1){ref-type="disp-formula"}--[3](#equ3){ref-type="disp-formula"}) applied to time-course experimental data under static and shaking conditions (i.e., [Figure 2A](#fig2){ref-type="fig"} and [Figure 2B](#fig2){ref-type="fig"}, respectively) allowed to extract the kinetic parameters in the model (see [Table 1](#tbl1){ref-type="table"}), in particular the rate constant for the cell-free infection (*β*) and the rate constant for the cell-to-cell infection (*ω*). However, from the estimated values of *β* and *ω*, we could not directly compare the efficiency of the two infection modes, because of the different units of measure of these parameters (p24/day for *β*, and cells/day for *ω*). To quantify each infection mode and overcome the above difficulty, we derived the basic reproduction number *R*~0~ ([@bib19]; [@bib17]; [@bib9]), an index reflecting the average number of newly infected cells produced from any one infected cell (see mathematical appendix in 'Materials and methods'). Note that secondly infected cells are produced from both the cell-free and cell-to-cell infection. Interestingly, in spite of nonlinear interaction between the two modes of virus transmission, our derivation of *R*~0~ revealed that the secondly infected cells were the sum of the basic reproduction number through the cell-free infection *R*~*cf*~ = *βpT*~*max*~/*δc* and the basic reproduction number through the cell-to-cell infection *R*~*cc*~ = *ωT*~*max*~/*δ*, (i.e., *R*~0~ = *R*~*cf*~ + *R*~*cc*~) (see [Figure 1B](#fig1){ref-type="fig"}). Using all accepted MCMC parameter estimates from the time-course experimental datasets, we calculated that on average the mean of the total basic reproductive number is *R*~0~ = 5.83 ± 0.94 (average ± standard deviation), and the mean number of secondly infected cells through the cell-free infection and the cell-to-cell infection are *R*~*cf*~ = 2.44 ± 0.23 and *R*~*cc*~ = 3.39 ± 0.91, respectively (see [Table 1](#tbl1){ref-type="table"}). The distributions of calculated *R*~0~, *R*~*cf*~, and *R*~*cc*~, are shown in [Figure 3A--C](#fig3){ref-type="fig"}, respectively. These estimates indicate that the contribution of the cell-to-cell infection is almost 60% on average (i.e., *R*~*cc*~/(*R*~*cc*~ + *R*~*cf*~) = 0.57 ± 0.07: [Table 1](#tbl1){ref-type="table"}) and this mode of infection is predominant during the HIV-1 spread in Jurkat cells. In [Figure 3D](#fig3){ref-type="fig"}, the distributions of calculated ratio are shown. Interestingly, this estimation is consistent with that by [@bib11], [@bib13], and [@bib12], although they did not take into account the difference of the death rate in the shaking and static conditions.10.7554/eLife.08150.009Figure 3.Distribution of the basic reproduction numbers, generation time, and Malthus coefficient.The distribution of the basic reproduction number, *R*~0~, the number of secondary infected cells through the cell-free infection, *R*~*cf*~, and the cell-to-cell infection, *R*~*cc*~, calculated from all accepted Markov Chain Monte Carlo (MCMC) parameter estimates are shown in **A**, **B**, and **C**, respectively. The contribution of the cell-to-cell infection (i.e., *R*~*cc*~/(*R*~*cf*~ + *R*~*cc*~)) is distributed as in **D**. For each plot, the last 15,000 MCMC samples among the total 50,000 samples are used. a.u., arbitrary unit.**DOI:** [http://dx.doi.org/10.7554/eLife.08150.009](10.7554/eLife.08150.009)

Advantage of cell-to-cell infection {#s2-3}
-----------------------------------

We also derived the viral generation time, defined as the time it takes for a population of virions to infect cells and reproduce ([@bib19]), from [Equations 1](#equ1){ref-type="disp-formula"}--[3](#equ3){ref-type="disp-formula"} in the static and shaking cell cultures (see mathematical appendix in 'Materials and methods'). In the presence and absence of the cell-to-cell infection (i.e., for the static and shaking cell cultures, respectively), the mean generation time is calculated as 1/*δ* + *R*~*cf*~/*cR*~0~ = 2.22 ± 0.32 days and 1/*δ* + 1/*c* = 2.47 ± 0.32 days, respectively (see [Table 2](#tbl2){ref-type="table"}). Thus, cell-to-cell infection shortens the generation time by on average 0.90 times, and enables HIV-1 to efficiently infect target cells ([@bib21]; [@bib3]). Furthermore, we calculated the Malthus coefficient, defined as the fitness of virus ([@bib17]; [@bib18]) (or the speed of virus infection) (see mathematical appendix in 'Materials and methods'). In the presence and absence of the cell-to-cell infection, the Malthus coefficient is calculated as 1.86 ± 0.37 and 0.49 ± 0.05 per day, respectively (see [Table 2](#tbl2){ref-type="table"}). Thus, cell-to-cell infection increases the HIV-1 fitness by 3.80-fold (corresponding to 944-fold higher viral load 5 days after the infection) and plays an important role in the rapid spread of HIV-1. Thus, the efficient viral spread via the cell-to-cell infection is relevant, especially at the beginning of virus infection.10.7554/eLife.08150.010Table 2.Generation time and Malthus coefficient of virus infection**DOI:** [http://dx.doi.org/10.7554/eLife.08150.010](10.7554/eLife.08150.010)Cell culture systemExp. 1Exp. 2Exp. 3Ave. ± S.D.Generation time of HIV-1 Static cell culture2.51[\*](#tblfn4){ref-type="table-fn"} days2.08 days2.22 days(2.22 ± 0.32)[‡](#tblfn6){ref-type="table-fn"} days(1.78--3.38) days(1.54--2.78) days(1.69--2.93) days-- Shaking cell culture2.73[†](#tblfn5){ref-type="table-fn"} days2.34 days2.47 days(2.47 ± 0.32) days(1.99--3.59) days(1.77--3.06) days(1.91--3.18) days--Malthus coefficient of HIV-1 Static cell culture1.61 day^−1^2.03 day^−1^1.86 day^−1^(1.86 ± 0.37) day^−1^(1.10--2.27) day^−1^(1.32--3.01) day^−1^(1.26--2.72) day^−1^-- Shaking cell culture0.57 day^−1^0.46 day^−11^0.49 day^−1^(0.49 ± 0.05) day^−1^(0.47--0.67) day^−1^(0.38--0.56) day^−1^(0.39--0.61) day^−1^--[^5][^6][^7][^8]

Virtual experiments of cell-to-cell infection in silico {#s2-4}
-------------------------------------------------------

While the shaking culture prevents the cell-to-cell infection, it is technically difficult to completely block the cell-free infection. Here, using our estimated kinetic parameters ([Table 1](#tbl1){ref-type="table"} and [Supplementary file 3](#SD3-data){ref-type="supplementary-material"}), we carried out a 'virtual experiment' eliminating the contribution of the cell-free infection using all accepted MCMC estimated parameter values, allowing to estimate only the cell-to-cell infection, in silico (see [Figure 4](#fig4){ref-type="fig"}). Our simulated mean values (represented by solid lines) of the cell-to-cell infection of HIV-1 are consistently located between the time course of experimental data under the static conditions (closed circles, including both the cell-free and cell to cell infections) and those under the shaking conditions (open circles, reflecting only the cell-free infection). The shadowed regions correspond to 95% posterior predictive intervals. In terms of the dynamics of infected cells and virus production, the simulated values corresponding to cell-to-cell virus propagation, are closer to experimental data from the coupled cell-free and cell-to-cell infection, than to data from the cell-free infection only. This shows that the cell-free infection, which contributes approximately 40% to the whole HIV-1 infection process, plays a limited role on the virus spread. In other words, even if we could completely block the cell-free infection, the cell-to-cell infection would still effectively spread viruses ([@bib27]). We address this point in 'Discussion'.10.7554/eLife.08150.011Figure 4.Simulating cell-to-cell infection of HIV-1.Using our estimated parameters, the pure cell-to-cell infection is simulated in silico (solid curves). The simulated values are located between the time course of experimental data under the static conditions (closed circles) and those under the shaking conditions (open circles). The shadowed regions correspond to 95% posterior predictive intervals.**DOI:** [http://dx.doi.org/10.7554/eLife.08150.011](10.7554/eLife.08150.011)

Discussion {#s3}
==========

Through experimental-mathematical investigation, here we quantitatively elucidated the dynamics of the cell-to-cell and cell-free HIV-1 infection modes ([Figure 2](#fig2){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). We derived the basic reproduction number, *R*~0~, and divided it into the numbers of secondly infected cells through the cell-free infection, *R*~*cf*~, and the cell-to-cell infection, *R*~*cc*~, respectively ([Figure 1B](#fig1){ref-type="fig"} and mathematical appendix in 'Materials and methods'). Based on our calculated values of these three indexes, we found that about 60% of the viral infection is attributed to the cell-to-cell infection in the in vitro cell culture system ([Table 1](#tbl1){ref-type="table"}), which is consistent with previous estimation by [@bib11], [@bib13], and [@bib12]. In addition, we revealed that the cell-to-cell infection effectively promotes the virus infection by reducing the generation time (×0.9 times), and by increasing the Malthus coefficient (×3.80 times) ([Table 2](#tbl2){ref-type="table"}).

When we consider the significance of the cell-to-cell infection in patients infected with HIV-1, it should be noted that the environment of immune cells including CD4^+^ T-cells in vivo is radically different from the conditions of in vitro cell cultures. For instance, lymphocytes are closely packed in lymphoid tissues such as lymph nodes, and thereby, the frequency for the infected cell to contact with adjacent uninfected cells in vivo would be much higher than that in in vitro cell cultures. In addition, Murooka et al. have directly demonstrated that HIV-1-infected cells converge to lymph nodes and can be vehicles for viral dissemination in vivo ([@bib16]). Moreover, certain studies have suggested that cell-to-cell viral spread is resistant to anti-viral immunity such as neutralizing antibodies and cytotoxic T lymphocytes ([@bib14]). Therefore, these notions strongly suggest that the contribution of the cell-to-cell infection for viral propagation in vivo may be much higher than that estimated from the in vitro cell culture system.

As another significance of cell-to-cell viral spread, Sigal et al. have suggested that the cell-to-cell infection permits viral replication even under the anti-retroviral therapy ([@bib27]). This is attributed to the fact that the multiplicity of infection per cell is tremendously higher than that reached by an infectious viral particle. However, in the previous report ([@bib27]), the contribution of the cell-to-cell infection remained unclear. To further understand the role of the cell-to-cell infection, we quantified the contributions of the cell-to-cell and cell-free infection modes ([Table 1](#tbl1){ref-type="table"}). Interestingly, we found that the cell-to-cell infection mode is predominant during the infection. Furthermore, our virtual experiments showed that a complete block of the cell-free infection, which is highly susceptible to current antiviral drugs, provides only a limited impact on the whole HIV-1 infection ([Figure 3](#fig3){ref-type="fig"}). Taken together, our findings further support that the cell-to-cell infection can be a barrier to prevent the cure of HIV-1 infection, which is discussed in [@bib27]. However, it should be noted that some papers have shown that cell-to-cell spread cannot overcome the action of most anti-HIV-1 drugs ([@bib30]; [@bib2]). To fully elucidate this issue, further investigations will be needed.

In addition to HIV-1, other viruses such as herpes simplex virus, measles virus, and human hepatitis C virus drive their dissemination via cell-to-cell infection ([@bib26]; [@bib29]). Although the impact of cell-to-cell viral spread is a topic of broad interest in virology, it was difficult to explore this issue by conventional virological experiments, because an infected cell is simultaneously capable of achieving cell-to-cell infection along with producing infectious viral particles. By applying mathematical modeling to the experimental data, here we estimated the sole dynamics of cell-free infection in the cell culture system. The synergistic strategy of experiments with mathematical modeling is a powerful approach to quantitatively elucidate the dynamics of virus infection in a way that is inaccessible through conventional experimental approaches.

Materials and methods {#s4}
=====================

Cell culture and HIV-1 infection {#s4-1}
--------------------------------

Jurkat cell line ([@bib31]) was cultured in the culture medium: RPMI 1640 (Sigma, St. Louis, MO) containing 2% fetal calf serum and antibiotics. The virus solution was prepared as previously described ([@bib22], [@bib24], [@bib25]; [@bib8]). Briefly, 30 μg of pNL4-3 plasmid ([@bib1]) (GenBank accession no. M19921.2) was transfected into 293T cells by the calcium-phosphate method. At 48 hr post-transfection, the culture supernatant was harvested, centrifuged, and then filtered through a 0.45-μm-pore-size filter to produce virus solution. The infectivity of virus solution was titrated as previously described ([@bib8]). Briefly, the virus solution obtained was serially diluted and then inoculated onto phytohemagglutinin-stimulated human peripheral blood mononuclear cells in a 96-well plate in triplicate. At 14 days postinfection, the endpoint was determined by using an HIV-1 p24 antigen enzyme-linked immunosorbent assay (ELISA) kit (ZetptoMetrix, Buffalo, NY) according to the manufacture\'s procedure, and virus infectivity was calculated as the 50% tissue culture infectious doses (TCID~50~) according to the Reed-Muench method.

For HIV-1 infection, 3 × 10^5^ of Jurkat cells were infected with HIV-1 (multiplicity of infection 0.1) at 37°C for 2 hr. The infected cells were washed three times with the culture medium, and then suspended with 3 ml of culture medium and seeded into a 25-cm^2^ flask (Nunc, Rochester, NY). For the static infection, the infected cell culture was kept in a 37°C/5% CO~2~ incubator as usual. For the shaking infection, the infected cell culture was handled as previously described ([@bib28]). Briefly, the cell culture was kept on a Petit rocker Model-2230 (Wakenyaku, Japan) placed in 37°C/5% CO~2~ incubator, and was gently shaken at 40 movements per min. The amount of virus particles in the culture supernatant and the number of infected cells were routinely measured as follows: a portion (300 μl) of the infected cell culture was routinely harvested, and the amount of released virions in the culture supernatant was quantified by using an HIV-1 p24 antigen ELISA kit (ZetptoMetrix) according to the manufacture\'s procedure. The cell number was counted by using a Scepter handled automated cell counter (Millipore, Germany) according to the manufacture\'s protocol. The percentage of infected cells was measured by flow cytometry. Flow cytometry was performed with a FACSCalibur (BD Biosciences, San Jose, CA) as previously described ([@bib22]; [@bib23], [@bib24], [@bib25]; [@bib8]), and the obtained data were analyzed with CellQuest software (BD Biosciences). For flow cytometry analysis, a fluorescein isothiocyanate-labeled anti-HIV-1 p24 antibody (KC57; Beckman Coulter, Pasadena, CA) was used. The representative dot plots are shown in [Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}. The data is available upon request. The remaining cell culture was centrifuged and then resuspended with 3 ml of fresh culture medium. It should be noted that the procedure for HIV-1 infection was performed at time *t* = −2 day in the figures. Because there is no viral protein production in the first day after infection, each in vitro experimental quantity was measured daily from *t* = 0 day (i.e., 2 days after HIV-1 inoculation). The detection threshold of each value are the followings: cell number (cell counting), 3000 cells/ml; % p24-positive cells (flow cytometry), 0.3%; and p24 antigen in culture supernatant (p24 antigen ELISA), 80 pg/ml.

Parameter estimation {#s4-2}
--------------------

A statistical model adopted in the Bayesian inference assumes measurement error to follow normal distribution with mean zero and unknown variance (error variance). A distribution of error variance is also inferred with the Gamma distribution as its prior distribution. Posterior predictive parameter distribution as an output of MCMC computation represents parameter variability. Distributions of model parameters and initial values were inferred directly by MCMC computations. On the other hand, distributions of the basic reproduction numbers and the other quantities were calculated from the inferred parameter sets ([Figure 3](#fig3){ref-type="fig"} for graphical representation). A set of computations for [Equations 1](#equ1){ref-type="disp-formula"}--[3](#equ3){ref-type="disp-formula"} with estimated parameter sets gives a distribution of outputs (virus load and cell density) as model prediction. To investigate variation of model prediction, global sensitivity analyses were performed. The range of possible variation is drawn in [Figure 2](#fig2){ref-type="fig"} as 95% confidence interval. Technical details of MCMC computations are summarized in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}.

Quantification of Jurkat cell growth {#s4-3}
------------------------------------

We here estimate the growth kinetics of Jurkat cells, which have been commonly used for HIV-1 studies, under the normal (i.e., mock-infected) condition with the following mathematical model:$$\frac{dT\left( t \right)}{dt} = gT\left( t \right)\left( {1 - \frac{T\left( t \right)}{T_{\mathit{\max}}}} \right),$$where the variable *T*(*t*) is the number of Jurkat cells at time t and the parameters *g* and *T*~*max*~ are the growth rate of the cells (i.e., Log2/*g* is the doubling time) and the carrying capacity of the cell culture flask, respectively. Nonlinear least-squares regression (*FindMinimum* package of *Mathematica9.0*) was performed to fit [Equation 4](#equ4){ref-type="disp-formula"} to the time-course numbers of Jurkat cells in the normal condition. The fitted parameter values are listed in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"} and the model behavior using these best-fit parameter estimates is presented together with the data in [Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}.

Mathematical appendix {#s4-4}
---------------------

The linearized equation of [Equations 1](#equ1){ref-type="disp-formula"}--[3](#equ3){ref-type="disp-formula"} at the virus-free steady state, (*T*~*max*~, 0, 0), is given as follows:$$\frac{dI\left( t \right)}{dt} = \beta T_{\mathit{\max}}V\left( t \right) + \omega T_{\mathit{\max}}I\left( t \right) - \delta I\left( t \right),$$$$\frac{dV\left( t \right)}{dt} = pI\left( t \right) - cV\left( t \right).$$

Let *b*(*t*) be the number of newly produced infected cells in the linear phase:$$b\left( t \right): = \beta T_{\mathit{\max}}V\left( t \right) + \omega T_{\mathit{\max}}I\left( t \right).$$

Applying the variation of constants formula to [Equations 5, 6](#equ5 equ6){ref-type="disp-formula"}, we have$$V\left( t \right) = V\left( 0 \right)e^{- ct} + {\int\limits_{0}^{t}e^{- c{({t - s})}}}pI\left( s \right)ds,$$$$I\left( t \right) = I\left( 0 \right)e^{- \delta t} + {\int\limits_{0}^{t}{e^{- \delta{({t - z})}}b\left( z \right)dz.}}$$

Inserting [Equation 9](#equ9){ref-type="disp-formula"} into [Equation 8](#equ8){ref-type="disp-formula"} to exchange the order of integrals, we have$$V\left( t \right) = g\left( t \right) + p\int\limits_{0}^{t}\int\limits_{0}^{x}e^{- c{({x - \theta})} - \delta\theta}d\theta b\left( t - x \right)dx,$$where$$g\left( t \right) : = V\left( 0 \right)e^{- ct} + \int\limits_{0}^{t}e^{- c{({t - s})}}pI\left( 0 \right)e^{- \delta t}ds.$$

From [Equation 7](#equ7){ref-type="disp-formula"} and [Equations 9, 10](#equ9 equ10){ref-type="disp-formula"}, we arrive at the following renewal equation:$$b\left( t \right) = h\left( t \right) + \int\limits_{0}^{t}\Psi\left( x \right)b\left( {t - x} \right)dx,$$where *h*(*t*) is given by$$h\left( t \right) : = \omega T_{max}I\left( 0 \right)e^{- \delta t} + \beta T_{max}g\left( t \right),$$and the kernel *Ψ*(*x*) is given by$$\Psi\left( x \right) : = \beta T_{max}p\int\limits_{0}^{x}e^{- \delta\theta - c{({x - \theta})}}d\theta + \omega T_{max}e^{- \delta x},$$$$= \frac{\beta T_{max}p}{\delta c}\left( {\phi_{1} \ast \phi_{2}} \right)\left( x \right) + \frac{\omega T_{max}}{\delta}\phi_{1}\left( x \right).$$

In the above expression, *ϕ*~*j*~(*x*) denotes the probability density function given by$$\phi_{1}\left( x \right) = \delta e^{- \delta x},\text{   }\phi_{2}\left( x \right) = ce^{- cx},$$and, ∗ denotes the convolution of functions. From the general theory of the basic reproduction number ([@bib7]), *R*~0~ for the reproduction of infected cells is given by$$R_{0} = \int\limits_{0}^{\infty}\Psi\left( x \right)dx = \frac{\beta T_{max}p}{\delta c} + \frac{\omega T_{max}}{\delta} = R_{cf} + R_{cc},$$where *R*~*cf*~ and *R*~*cc*~ denote the reproduction numbers for infected cells mediated by the cell-free and cell-to-cell infection, respectively.

Next we consider the reproduction process of viruses. Let *ρ*(*t*):= *pI*(*t*) be the number of newly produced viruses at time *t*. From [Equations 8, 9](#equ8 equ9){ref-type="disp-formula"}, we obtain$$\rho\left( t \right) = pI\left( 0 \right)e^{- \delta t} + \int\limits_{0}^{t}e^{- \delta{(t - z)}}\left( {\beta T_{max}pV\left( z \right) + \omega T_{max}\rho\left( z \right)} \right)dz,\,$$where$$V\left( t \right) = V\left( 0 \right)e^{- ct} + \int\limits_{0}^{t}e^{- c{({t - s})}}\rho\left( s \right)ds.$$

Inserting [Equation 11](#equ11){ref-type="disp-formula"} into [Equation 12](#equ19){ref-type="disp-formula"}, we again arrive at the following renewal equation:$$\rho\left( t \right) = q\left( t \right) + \int\limits_{0}^{t}\Psi\left( x \right)\rho\left( {t - x} \right)dx,$$where *q*(*t*) is given by$$q\left( t \right) : = pI\left( 0 \right)e^{- \delta t} + \int\limits_{0}^{t}e^{- \delta{({t - z})}}p\beta T_{max}V\left( 0 \right)e^{- cz}dz.$$

Note that the reproduction kernel *Ψ*(*x*) for the virus reproduction is the same as the kernel for the cell reproduction. Thus the probability density function of the virus reproduction is given by$$\psi\left( x \right) : = \frac{\Psi\left( x \right)}{R_{0}} = \frac{R_{cf}}{R_{0}}\left( {\phi_{1} \ast \phi_{2}} \right)\left( x \right) + \frac{R_{cc}}{R_{0}}\phi_{1}\left( x \right).$$

Then the generation time for the virus reproduction, denoted by *G*, is calculated as follows:$$G : = \int\limits_{0}^{\infty}t\psi\left( t \right)dt = \frac{R_{cf}}{R_{0}}G_{cf} + \frac{R_{cc}}{R_{0}}G_{cc} \leq G_{cf},$$where *G*~*cf*~ : = 1/*δ* + 1/*c* and *G*~*cc*~ : = 1/*δ* are the generation times for virus reproduction mediated by the cell-free and cell-to-cell infection, respectively.

The Malthusian coefficient for the virus reproduction must be given as the dominant real root of the Euler-Lotka equation as$$\int\limits_{0}^{\infty}e^{- \lambda x}\Psi\left( x \right)dx = \frac{\beta T_{max}p}{\delta c}\hat{\phi_{1}}\left( \lambda \right)\hat{\phi_{2}}\left( \lambda \right) + \frac{\omega T_{max}}{\delta}\hat{\phi_{1}}\left( \lambda \right) = 1,$$where $\hat{\phi_{j}}$ denotes the Laplace transformation of a function *ϕ*~*j*~. That is,$$\hat{\phi_{1}}\left( \lambda \right) = \int\limits_{0}^{\infty}e^{- \lambda x}\phi_{1}\left( x \right)ds = \frac{\delta}{\delta + \lambda},\,\hat{\phi_{2}}\left( \lambda \right) = \int\limits_{0}^{\infty}e^{- \lambda x}\phi_{2}\left( x \right)ds = \frac{c}{c + \lambda}.$$

Therefore the Euler-Lotka equation can be calculated explicitly as follows:$$\frac{\beta T_{max}p}{\delta c}\frac{\delta c}{\left( {\delta + \lambda} \right)\left( {c + \lambda} \right)} + \frac{\omega T_{max}}{\delta}\frac{\delta}{\delta + \lambda} = 1,$$which is reduced to a quadratic equation,$$\lambda^{2} + \delta c\left( {G_{cc} + \left( {1 - R_{cc}} \right)\left( {G_{cf} - G_{cc}} \right)} \right)\lambda + \delta c\left( {1 - R_{0}} \right) = 0.\,$$

If *R*~0~ \> 1, [Equation 13](#equ27){ref-type="disp-formula"} has a unique positive root, which is no other than the Malthusian coefficient for the virus reproduction, so it is calculated as,$$\lambda = \frac{- \delta c\left( {G_{cc} + \left( {1 - R_{cc}} \right)\left( {G_{cf} - G_{cc}} \right)} \right) + \sqrt{\delta^{2}c^{2}\left( {G_{cc} + \left( {1 - R_{cc}} \right)\left( {G_{cf} - G_{cc}} \right)} \right)^{2} - 4\delta c\left( 1 - R_{0} \right)}}{2}.$$
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for submitting your work entitled "Cell-to-cell infection by HIV contributes over half of virus infection" for peer review at *eLife*. Your submission has been favorably evaluated by Naama Barkai (Senior Editor), a Reviewing Editor, and two reviewers. One of the two reviewers, Vitaly Ganusov, has agreed to share his identity.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

While others have previously shown that cell-to-cell spread is a rapid and efficient form of infection, the novelty of this work is in its attempt to quantify the contributions of cell-to-cell spread and cell-free infection in the same culture. However, there are three major concerns about the connections between the experiments and assumptions made in the modeling that need to be addressed in order to ascertain that the conclusions are correct. These major concerns are:

1\) The parameter, *ω*, which measures the infection rate by cell-to-cell spread is obtained by fitting the model to data, and it is assumed that *ω*=0 in the experiments with shaking. *β*, the cell-free infection rate, is assumed to be the same under both infection conditions. In the data, shaking reduces infection, consistent with decreased cell-to-cell spread. However, it is also consistent with several other possibilities. For example, reduction of both cell-to-cell spread and cell-free infection due to many possible factors including lower production rates or infectivity of virus. If this is true, a similar attenuation of viral dynamics would be observed upon shaking but for a completely different reason, and invalidate the assumptions made to fit the data. To prove that the attenuated viral dynamics are strictly the result of a loss of cell-to-cell spread, a control experiment is needed. It is up to you to choose the appropriate control experiment that establishes this. We think that the following experiment might be appropriate:

Produce cell-free virus by filtering out any cells, then add it to either shaking or static Jurkat cell cultures and measure the percent infected cells under each condition at a few time points before two days (i.e. before the second cycle of infection). If shaking only affects cell-to-cell transmission, the results should be identical for shaken or static cultures in this experiment.

2\) The parameter values are taken to be constant in time, but this may not be the case. Consider the parameter *g*, as an example. Cells that reach a maximum density may go into growth arrest and there is a lag time to get them out of it. This would mean that g is not constant. Is there experimental evidence that the parameters do not change with time. Also, at high levels of infection, which appears to be true in the experiments, is the cell culture still stable? If not, *g* would not be a constant.

3\) It seems that the simulations are carried out without virus removal (without c) for 24 hours, and then an instantaneous removal occurs at 90% (not continuous removal of the virus as 2.3 per day). This set-up does not seem congruent with the experiments. The simulations should be carried out in a similar way to the experimental set-up to make sure that the parameter values are properly estimated. In addition, is it certain that cells/infected cells are not removed in the experiments, as it seems is assumed in the model? Finally, more quantitative estimates of agreement between the fitted models and experimental data are required. For example, by visual inspection of [Figure 2](#fig2){ref-type="fig"}, one could argue that the model does not describe the loss of infected cells and the virus after the peak well ([Figure 2A](#fig2){ref-type="fig"}), and in [Figure 2B](#fig2){ref-type="fig"}, it is not clear how good the fits are. Error bars need to be provided for the estimated parameters in [Table 1](#tbl1){ref-type="table"}.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled "Cell-to-cell infection by HIV contributes over half of virus infection" for further consideration at *eLife*. Your revised article has been favorably evaluated by Naama Barkai (Senior Editor), a Reviewing Editor, and one of the original reviewers. The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

We have read your response and revised manuscript, and believe that you have not addressed the first major and essential point. As discussed in the first report, the assumption you make is that shaking eliminates cell-to-cell spread but does not affect cell-free infection. The premise of the whole paper is based on this assumption. According to the data presented in [Figure 2](#fig2){ref-type="fig"}, this may not be the case: Day 0 infection as shown in the middle panels of [Figure 2A](#fig2){ref-type="fig"} (static) and [Figure 2B](#fig2){ref-type="fig"} (shaking) is strictly the result of cell-free infection, as you indicate in the Methods. In [Figure 2A](#fig2){ref-type="fig"} (static), the number of cell infected is between 10^3^ to 10^4^/ml. In [Figure 2B](#fig2){ref-type="fig"} (shaking), the number of infected cells -- by what is supposed to be the same cell-free infection input according to the methods -- seems to be undetectable at day 0, with the first measurements appearing at a later time. This indicates that shaking, at least as performed by the method used in this paper, decreases cell-free infection. We requested that you perform a control experiment to show that this is not the case, and that shaking does not affect cell-free infection. We had also suggested a simple experiment for you to consider: add cell-free virus to static and shaking cultures and show that the infection rate is unaffected by shaking at the first infection cycle (subsequent cycles would involve cell-to-cell spread due to the co-culture, and would not be relevant). Rather than carry out this (or some other) control experiment, you point to a past paper that showed this. But, given the data in [Figure 2](#fig2){ref-type="fig"} (see above), it is unclear that the assumption that shaking does not affect cell free infection is correct in your experiment. Since the rest of the work presented in the paper relies on this assumption, a control experiment demonstrating this assumption to be true is necessary.

10.7554/eLife.08150.016

Author response

*While others have previously shown that cell-to-cell spread is a rapid and efficient form of infection, the novelty of this work is in its attempt to quantify the contributions of cell-to-cell spread and cell-free infection in the same culture. However, there are three major concerns about the connections between the experiments and assumptions made in the modeling that need to be addressed in order to ascertain that the conclusions are correct. These major concerns are*:

*1) The parameter,* ω*, which measures the infection rate by cell-to-cell spread is obtained by fitting the model to data, and it is assumed that* ω*=0 in the experiments with shaking.* β*, the cell-free infection rate, is assumed to be the same under both infection conditions. In the data, shaking reduces infection, consistent with decreased cell-to-cell spread. However, it is also consistent with several other possibilities. For example, reduction of both cell-to-cell spread and cell-free infection due to many possible factors including lower production rates or infectivity of virus. If this is true, a similar attenuation of viral dynamics would be observed upon shaking but for a completely different reason, and invalidate the assumptions made to fit the data. To prove that the attenuated viral dynamics are strictly the result of a loss of cell-to-cell spread, a control experiment is needed. It is up to you to choose the appropriate control experiment that establishes this. We think that the following experiment might be appropriate*:

*Produce cell-free virus by filtering out any cells, then add it to either shaking or static Jurkat cell cultures and measure the percent infected cells under each condition at a few time points before two days (i.e. before the second cycle of infection). If shaking only affects cell-to-cell transmission, the results should be identical for shaken or static cultures in this experiment*.

In the original publication (Sourisseau et al., J Virol, 2007) describing the experimental model that we used here, the authors carefully verified that shaking did not induce nonspecific consequences on HIV infection. Namely, they verified that static and shaking conditions did not induce differences in cell viability, cell growth rate, expression level of receptor/co-receptors and adhesion molecules ([Figure 2](#fig2){ref-type="fig"} in Sourisseau et al., J Virol, 2007). The authors also verified the absence of effect on virus release and on the efficiency of cell-free virus infection ([Figure 3](#fig3){ref-type="fig"} in Sourisseau et al., J Virol, 2007). The previous demonstration of the absence of nonspecific consequences on HIV replication is now indicated in the manuscript (subsection "Adaptation of a mathematical model to explicitly consider cell-free and cell-to-cell infection").

*2) The parameter values are taken to be constant in time, but this may not be the case. Consider the parameter* g*, as an example. Cells that reach a maximum density may go into growth arrest and there is a lag time to get them out of it. This would mean that g is not constant. Is there experimental evidence that the parameters do not change with time. Also, at high levels of infection, which appears to be true in the experiments, is the cell culture still stable? If not,* g *would not be a constant*.

Thank you for pointing this out, we would like to explain our assumption in detail, especially for the growth rate. In [Equation (1)](#equ1){ref-type="disp-formula"}, we assumed the growth of target cells is described by *g*{1−(*T*(*t*)+*I*(*t*))/*T*~*max*~}*T*(*t*). This is called "logistic growth". In this formulation, *g*{1−(*T*(*t*)+*I*(*t*))/*T*~*max*~} represents the average growth rate per cell. That is, if the density of total cells (i.e. *T*(*t*)+*I*(*t*)) is low, then the growth rate is approximately *g*, but if the density is high (i.e., around maximum density, *T*~*max*~), then the growth rate becomes 0, which models cell growth arrest. Because the term of 1−(*T*(*t*)+*I*(*t*))/*T*~*max*~ is a function of time, the average growth rate gradually decrease from 1 to 0 as the density increases from low to maximum, which shows a lag time. Thus, the logistic formulation well captures the density-dependent cell growth in cell culture as we previously showed in [@bib6]. In contrast, for other parameters, we simply assumed they are constant. However, at least, in cell culture system, many papers including our own studies ([@bib6]; Iwami et al., Retrovirology, 2012; Iwami et al., Front Microbiol., 2012; Komarova et al., 2013; [@bib10]; Beauchemin et al., 2008) has shown that the simple constant assumption sufficiently reproduced the infection dynamics and quantified parameters reasonably. Therefore, we would like to keep our parameters constant in order to avoid the complexity of time-dependent parameters and to allow the use of our novel model for the cell-to-cell and cell-free HIV-1 infections.

*3) It seems that the simulations are carried out without virus removal (without c) for 24 hours, and then an instantaneous removal occurs at 90% (not continuous removal of the virus as 2.3 per day). This set-up does not seem congruent with the experiments. The simulations should be carried out in a similar way to the experimental set-up to make sure that the parameter values are properly estimated. In addition, is it certain that cells/infected cells are not removed in the experiments, as it seems is assumed in the model? Finally, more quantitative estimates of agreement between the fitted models and experimental data are required. For example, by visual inspection of* [*Figure 2*](#fig2){ref-type="fig"}*, one could argue that the model does not describe the loss of infected cells and the virus after the peak well (*[*Figure 2A*](#fig2){ref-type="fig"}*), and in* [*Figure 2B*](#fig2){ref-type="fig"}*, it is not clear how good the fits are. Error bars need to be provided for the estimated parameters in* [*Table 1*](#tbl1){ref-type="table"}*.*

In addressing this very relevant and important comment, we have made a number of changes to our manuscript but also to our analysis itself. First, we would like to explain our assumption in [Equations (1](#equ1){ref-type="disp-formula"}-[3)](#equ3){ref-type="disp-formula"} for the removal due to the experimental samplings. For each of the daily measurements of the virus concentration, the medium in our experiments was harvested, reducing the viral concentration by 90%. This removal can be captured using [Equation (3)](#equ3){ref-type="disp-formula"} by approximating the punctual removal of virus at each sampling time as a continuous, exponential decay of the viral load over the period between samples. In such a case, parameter *c* corresponds to the sum of the rate of virus loss due to harvesting of the medium plus the rate of loss due to degradation of the extracellular virus (which is negligibly small). In addition, on a daily basis, 10% of the cells in the culture were harvested to measure the number of target cells and infected cells. Similarly, the removals of the target and infected cells were included in the value of *g* and δ, respectively. We clarified this assumption by adding a few sentences to the subsection "Adaptation of a mathematical model to explicitly consider cell-free and cell-to-cell infection".10.7554/eLife.08150.017Author response image 1.Punctual model for parameter estimation.The time course of experimental data for the numbers of uninfected cells (top) and infected cells (middle), and the amount of viral p24 antigen (bottom) in the static (left) and shaking (right) culture systems, respectively. The solid curves depict the best fit of the punctual model to the time-course dataset. All data in the experiment 3 were fitted simultaneously. For the experiments 1 and 2, we obtained similar fitting and parameter estimation values (data not shown).**DOI:** [http://dx.doi.org/10.7554/eLife.08150.017](10.7554/eLife.08150.017)

As an example, we have expanded our analysis using [Equations (1](#equ1){ref-type="disp-formula"}-[3)](#equ3){ref-type="disp-formula"} to also include an analysis of the experimental data using the model with punctual removal, i.e. we determined best-fit parameters for this punctual model and present graphs of its agreement to both data sets over time ([Author response image 1](#fig5){ref-type="fig"}). Generally, the punctual removal model describes the experimental data well, and the estimated values for the model parameters are similar to those found using [Equations (1](#equ1){ref-type="disp-formula"}-[3)](#equ3){ref-type="disp-formula"}; *β*=3.49×10^−6^, *ω*=1.17×10^−6^, *p*=0.53, *δ*=0.50 in [Eqs.(1](#equ1){ref-type="disp-formula"}-[3)](#equ3){ref-type="disp-formula"}, and *β*=6.65×10^−6^, *ω*=1.69×10^−6^, *p*=0.13, *δ*=0.43 in the punctual model. In our earlier works ([@bib6]; Iwami et al., Retrovirology, 2012; Iwami et al., Front Microbiol., 2012; [@bib10]) we have also shown that approximating punctual removal as a continuous exponential decay has minimal impact on the model parameters and provides an appropriate fit to the experimental data. And also, unfortunately, we could not define the basic reproduction numbers such as *R*~*cf*~, *R*~*cc*~, and *R*~0~ for the punctual model because of its discontinuity. Quantifying these values and comparing them are key findings of this paper. Therefore, we used the exponential decay approximation (i.e. [Equations (1](#equ1){ref-type="disp-formula"}-[3)](#equ3){ref-type="disp-formula"} here. Nevertheless, we do feel that inclusion of the above discussion about the punctual removal is a valuable addition to our manuscript and improves the completeness of our work (see the second paragraph of the subsection "Adaptation of a mathematical model to explicitly consider cell-free and cell-to-cell infection").

Furthermore, for more quantitative estimates of agreement between the fitted models and experimental data, we performed Bayesian estimation for the whole dataset using Markov Chain Monte Carlo (MCMC) sampling. The Bayesian estimation enables us to assess the variability of kinetic parameters and model prediction as posterior predictive intervals (see Results, Methods and [Supplementary file 1).](#SD1-data){ref-type="supplementary-material"} We thank the reviewers for leading us in this direction.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

*We have read your response and revised manuscript, and believe that you have not addressed the first major and essential point. As discussed in the first report, the assumption you make is that shaking eliminates cell-to-cell spread but does not affect cell-free infection. The premise of the whole paper is based on this assumption. According to the data presented in* [*Figure 2*](#fig2){ref-type="fig"}*, this may not be the case: Day 0 infection as shown in the middle panels of* [*Figure 2A*](#fig2){ref-type="fig"} *(static) and* [*Figure 2B*](#fig2){ref-type="fig"} *(shaking) is strictly the result of cell-free infection, as you indicate in the Methods. In* [*Figure 2A*](#fig2){ref-type="fig"} *(static), the number of cell infected is between 10*^*3*^ *to 10*^*4*^*/ml. In* [*Figure 2B*](#fig2){ref-type="fig"} *(shaking), the number of infected cells -- by what is supposed to be the same cell-free infection input according to the methods -- seems to be undetectable at day 0, with the first measurements appearing at a later time. This indicates that shaking, at least as performed by the method used in this paper, decreases cell-free infection. We requested that you perform a control experiment to show that this is not the case, and that shaking does not affect cell-free infection. We had also suggested a simple experiment for you to consider: add cell-free virus to static and shaking cultures and show that the infection rate is unaffected by shaking at the first infection cycle (subsequent cycles would involve cell-to-cell spread due to the co-culture, and would not be relevant). Rather than carry out this (or some other) control experiment, you point to a past paper that showed this. But, given the data in* [*Figure 2*](#fig2){ref-type="fig"} *(see above), it is unclear that the assumption that shaking does not affect cell free infection is correct in your experiment. Since the rest of the work presented in the paper relies on this assumption, a control experiment demonstrating this assumption to be true is necessary*.

According to the suggestion raised by the editors ("it is unclear that the assumption that shaking does not affect cell free infection is correct in your experiment"), we carried out an additional experiment and the data is shown as [Figure 2--figure supplement 1](#fig2s1){ref-type="fig"}. As shown, we have clearly verified that the shaking procedure does not affect the efficacy of cell-free infection.

[^1]: These authors contributed equally to this work.

[^2]: Mean value.

[^3]: 95% confidence interval.

[^4]: Average and standard deviation of merged values in experiment 1, 2, and 3.

[^5]: Mean value.

[^6]: 95% confidence interval.

[^7]: Average and standard deviation of merged values in experiment 1, 2, and 3.

[^8]: HIV-1, human immunodeficiency virus type 1.
